A new study is paving the way for hormone-free birth control after kegg, a fertility monitor accurately measured changes in cervical fluid instead of basal body temperature, which is commonly used.
The study presented at the 2023 meeting of the Society of Reproductive Investigation by Lady Technologies showed that monitoring changes in cervical fluid is more descriptive of fertile cycles than basal body temperature. The study showed that monitoring changes in cervical fluid is more descriptive of fertile cycles than basal body temperature.
According to Lady Technologies founder Kristina Cahojova, “Social media is giving women a voice to publicly discuss adverse effects of pharmaceutical birth control. Women are looking for alternatives but there aren’t many. We want to bring them a reliable alternative. There is enough evidence that cervical fluid is the way to get there. We are the only company in this space and exciting research is underway. The market size will soon exceed $30 billion and we want to serve the women in it that desire natural alternatives.”
kegg, the only fertility monitor on the market that measures changes in cervical fluid instead of basal body temperature, a key component of many hormone-free birth control methods in use today. By measuring changes in cervical fluid, kegg intends to use the study’s findings and key elements within its technology to research pathways to creating a non-hormonal birth control.
No other product on the public market is able to collect and study vaginal mucus, and give women similar insights into their fertility and health in the comfort of their own homes.
After the success of their study, Lady Technologies has secured a clinical site for testing, to further evaluate how their product excels in women’s health and fertility. Lady Technologies’ studies are in collaboration with reproductive health thought leaders at major universities to further our understanding of the science around cervical fluid and provide women valuable insights into their health.
This study shows why kegg is a game changer for many in the fertility market. Most IUDs and birth control pills target cervical fluid so that sperm cannot enter the cervix. The thickened cervical fluid then acts as a barrier preventing sperm movement.
kegg takes a different approach that monitors the fertile window by evaluating the changes in the cervical fluid.
Lady Technologies’ approach of sensing changes in cervical fluid can be pivotal in bringing women the most reliable alternative natural solution to pharmaceutical birth control.
